STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 and ERK signaling

European Journal of Cancer

Volumn 46, Issue 16, 2010, Pages 2996-3006

  Wang, Zhenlian ^a,b,c   Luo, Feijun ^a,b   Li, Lili ^a,b   Yang, Lifang ^a,b   Hu, Duosha ^a,b   Ma, Xiaoqian ^a,b   Lu, Zhongxin ^a,b   Sun, Lunquan ^a,b   Cao, Ya ^a,b  

^a The First People s Hospital of Changde City)   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Epstein Barr virus; Extracellular signal regulated kinase 1 2; Invasion ability; Janus kinase 3; Latent membrane protein 1; Nasopharyngeal carcinoma; PD98059; Signal transducer and activator of transcription 3; Vascular endothelial growth factor; WHI P131

Indexed keywords

JANUS KINASE 3; LATENT MEMBRANE PROTEIN 1; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT3 PROTEIN; VASCULOTROPIN;

ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE ACTIVATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE;

BLOTTING, WESTERN; CELL LINE, TUMOR; HUMANS; JANUS KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTORS; VIRAL MATRIX PROTEINS;

EID: 78049295535     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.07.008     Document Type: Article

References (60)

1. K.W. Lo, K.F. To, and D.P. Huang Focus on nasopharyngeal carcinoma Cancer Cell 5 2004 423 428
2. N. Raab-Traub Epstein-Barr virus in the pathogenesis of NPC Semin Cancer Biol 12 2002 431 441
3. M.L. Hammarskjold, and M.C. Simurda Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity J Virol 66 1992 6496 6501
4. A. Kieser, E. Kilger, and O. Gires Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade EMBO J 16 1997 6478 6485
5. C.W. Dawson, G. Tramountanis, A.G. Eliopoulos, and L.S. Young Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling J Biol Chem 278 2003 3694 3704
6. B.A. Mainou, D.N. Everly Jr., and N. Raab-Traub Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K Oncogene 24 2005 6917 6924
7. L. Li, L. Guo, and Y. Tao Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases Cancer Lett 255 2007 219 231
8. M.L. Roberts, and N.R. Cooper Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation Virology 240 1998 93 99
9. C.W. Dawson, L. Laverick, M.A. Morris, G. Tramoutanis, and L.S. Young Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway J Virol 82 2008 3654 3664
10. J.E. Floettmann, A.G. Eliopoulos, M. Jones, L.S. Young, and M. Rowe Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions Oncogene 17 1998 2383 2392
11. C.A. Fielding, K. Sandvej, and A. Mehl Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways J Virol 75 2001 9129 9141
12. A.G. Eliopoulos, N.J. Gallagher, S.M. Blake, C.W. Dawson, and L.S. Young Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production J Biol Chem 274 1999 16085 16096
13. O. Gires, F. Kohlhuber, and E. Kilger Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins EMBO J 18 1999 3064 3073
14. R. Pathmanathan, U. Prasad, R. Sadler, K. Flynn, and N. Raab-Traub Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma N Engl J Med 333 1995 693 698
15. S.W. Tsao, G. Tramoutanis, C.W. Dawson, A.K. Lo, and D.P. Huang The significance of LMP1 expression in nasopharyngeal carcinoma Semin Cancer Biol 12 2002 473 487
16. T. Yoshizaki Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1 Histol Histopathol 17 2002 845 850
17. T. Horikawa, T. Yoshizaki, T.S. Sheen, S.Y. Lee, and M. Furukawa Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma Cancer 89 2000 715 723
18. L.F. Hu, F. Chen, and Q.F. Zhen Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas Eur J Cancer 31A 1995 658 660
19. Y.P. Liu, Y.N. Tan, and Z.L. Wang Phosphorylation and nuclear translocation of STAT3 regulated by the Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma Int J Mol Med 21 2008 153 162
20. H. Chen, L. Hutt-Fletcher, L. Cao, and S.D. Hayward A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus J Virol 77 2003 4139 4148
21. R.J. Leeman, V.W. Lui, and J.R. Grandis STAT3 as a therapeutic target in head and neck cancer Expert Opin Biol Ther 6 2006 231 241
22. B.B. Ma, V.W. Lui, and F.F. Poon Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response Invest New Drugs 28 2010 326 333
23. Y.N. Tan, Y.G. Tao, and X. Song Expression of JAK3 in nasopharyngeal carcinoma cell line associated with STAT activation regulated by EB virus encoded protein LMP1 Prog Biochem Biophys 30 2003 560 565
24. H. Zheng, L.L. Li, D.S. Hu, X.Y. Deng, and Y. Cao Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma Cell Mol Immunol 4 2007 185 196
25. J.J. Schuringa, H. Schepers, E. Vellenga, and W. Kruijer Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation FEBS Lett 495 2001 71 76
26. L. O'Rourke, and P.R. Shepherd Biphasic regulation of extracellular-signal-regulated protein kinase by leptin in macrophages: role in regulating STAT3 Ser727 phosphorylation and DNA binding Biochem J 364 2002 875 879
27. J. Turkson, and R. Jove STAT proteins: novel molecular targets for cancer drug discovery Oncogene 19 2000 6613 6626
28. J. Chung, E. Uchida, T.C. Grammer, and J. Blenis STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation Mol Cell Biol 17 1997 6508 6516
29. R.K. Lo, H. Cheung, and Y.H. Wong Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism J Biol Chem 278 2003 52154 52165
30. G. Niu, K.L. Wright, and M. Huang Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis Oncogene 21 2002 2000 2008
31. Z.X. Lu, M. Ye, and G.R. Yan Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis Cancer Gene Ther 12 2005 647 654
32. C. Beadling, J. Ng, J.W. Babbage, and D.A. Cantrell Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway EMBO J 15 1996 1902 1913
33. X. Wang, S.C. Wong, and J. Pan Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells Cancer Res 58 1998 5019 5022
34. G. Yan, L. Li, and Y. Tao Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology Proteomics 6 2006 1810 1821
35. L.B. Mora, R. Buettner, and J. Seigne Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells Cancer Res 62 2002 6659 6666
36. R. Chiarle, W.J. Simmons, and H. Cai Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target Nat Med 11 2005 623 629
37. B.E. Barton, J.G. Karras, T.F. Murphy, A. Barton, and H.F. Huang Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: direct STAT3 inhibition induces apoptosis in prostate cancer lines Mol Cancer Ther 3 2004 11 20 (Pubitemid 39193674)
38. S.M. Elbashir, J. Harborth, and W. Lendeckel Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 2001 494 498
39. E. Fujimoto, H. Sato, and S. Shirai Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line Oncogene 24 2005 3684 3690
40. L. Konnikova, M. Kotecki, M.M. Kruger, and B.H. Cochran Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells BMC Cancer 3 2003 23
41. T. Horikawa, T.S. Sheen, and H. Takeshita Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma Am J Pathol 159 2001 27 33 (Pubitemid 33704188)
42. K.R. Kim, T. Yoshizaki, and H. Miyamori Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth Oncogene 19 2000 1764 1771
43. S. Kondo, S.Y. Seo, and T. Yoshizaki EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells Cancer Res 66 2006 9870 9877
44. S. Murono, T. Yoshizaki, and H. Sato Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression Cancer Res 60 2000 2555 2561
45. S. Murono, H. Inoue, and T. Tanabe Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells Proc Natl Acad Sci USA 98 2001 6905 6910
46. H. Takeshita, T. Yoshizaki, and W.E. Miller Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2 J Virol 73 1999 5548 5555
47. N. Wakisaka, S. Murono, T. Yoshizaki, M. Furukawa, and J.S. Pagano Epstein-Barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2 Cancer Res 62 2002 6337 6344
48. N. Wakisaka, S. Kondo, and T. Yoshizaki Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha Mol Cell Biol 24 2004 5223 5234
49. T. Yoshizaki, H. Sato, M. Furukawa, and J.S. Pagano The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1 Proc Natl Acad Sci USA 95 1998 3621 3626
50. S. Kondo, N. Wakisaka, and M.J. Schell Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma Int J Cancer 115 2005 368 376
51. H. Yu, and R. Jove The STATs of cancer - new molecular targets come of age Nat Rev Cancer 4 2004 97 105
52. L. Zhang, K. Hong, J. Zhang, and J.S. Pagano Multiple signal transducers and activators of transcription are induced by EBV LMP-1 Virology 323 2004 141 152
53. S. Kondo, T. Yoshizaki, and N. Wakisaka MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling J Virol 81 2007 1554 1562
54. A.K. Lo, K.W. Lo, and S.W. Tsao Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells Neoplasia 8 2006 173 180
55. Z. Wen, Z. Zhong, and J.E. Darnell Jr Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation Cell 82 1995 241 250
56. Y.N. Tan, Y.G. Tao, and L.L. Li Regulation of human VEGF expression by latent membrane protein 1 encoded by EB virus via STAT3 in nasopharyngeal carcinoma cell line Prog Biochem Biophys 31 2004 427 431
57. T. Yoshizaki, T. Horikawa, and R. Qing-Chun Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma Clin Cancer Res 7 2001 1946 1951 (Pubitemid 32994829)
58. K. Endo, S. Kondo, and J. Shackleford Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration Oncogene 28 2009 1725 1735
59. C.H. Ho, C.L. Chen, W.Y. Li, and C.J. Chen Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion Carcinogenesis 30 2009 1443 1451
60. T. Horikawa, J. Yang, and S. Kondo Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma Cancer Res 67 2007 1970 1978